Gunjan Thiagarajah

Vice President Marketing Inflammation

Gunjan is the Vice-President of Marketing for the Inflammation Business Unit and leads Amgen’s U.S. Dermatology, Rheumatology, and Gastroenterology marketing teams that are responsible for Otezla, Enbrel, Avsola, Amjevita, and ABP 654 (biosimilar to Stelara).
Gunjan has shaped strategy, launched and driven execution in multiple U.S. roles in Marketing, Sales, Value & Access, and Strategy across Inflammation, Oncology, and Nephrology. She has also served in Global commercial roles, leading Bone Health and enabling transformation as part of the Results Delivery Office. Prior to Amgen, she worked as a healthcare consultant with Deloitte. Her educational foundation is Engineering from Rutgers University and an MBA from UCLA.

Talks About
#marketing

Preferred Locations
#Northamerica